Boulder, CO, United States of America

Jens Eberlein

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jens Eberlein: Innovator in Nucleic Acid Sample Preparation

Introduction

Jens Eberlein is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of nucleic acid sample preparation, particularly in the context of immune repertoire sequencing. His work has implications for advancing our understanding of immune responses and developing new therapeutic strategies.

Latest Patents

Jens Eberlein holds 1 patent titled "Methods of nucleic acid sample preparation for immune repertoire sequencing." This patent encompasses methods for preparing and analyzing nucleic acids, specifically those encoding immune receptors and immunoglobulins. The technology disclosed in this patent provides innovative approaches for preparing nucleic acids for sequence analysis, including the use of next-generation sequencing techniques.

Career Highlights

Eberlein is currently associated with Archerdx, LLC, where he applies his expertise in nucleic acid technologies. His work at Archerdx focuses on developing advanced methods that enhance the analysis of immune repertoires, contributing to the broader field of immunology and personalized medicine.

Collaborations

Throughout his career, Jens has collaborated with talented individuals such as Jason Myers and Joshua Stahl. These collaborations have fostered an environment of innovation and have led to advancements in the technologies related to immune repertoire sequencing.

Conclusion

Jens Eberlein's contributions to nucleic acid sample preparation and immune repertoire sequencing highlight his role as an influential inventor in the field. His work continues to pave the way for new discoveries and applications in immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…